MiRNA-4537 functions as a tumor suppressor in gastric cancer and increases the radiosensitivity of gastric cancer cells

References

• Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000 Dec;3(4):219–225. PubMed PMID: 11984739; eng.
   PubMedGoogle Scholar
• Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10(1):1–11. PubMed PMID: 17334711; eng.
   PubMed Web of Science ®Google Scholar
• Thrumurthy SG, Chaudry MA, Hochhauser D, et al. The diagnosis and management of gastric cancer. BMJ (Clin Res Ed). 2013 Nov 4;347:f6367. PubMed PMID: 24191271; eng.
   PubMedGoogle Scholar
• Hajj C, Goodman KA. Role of radiotherapy and newer techniques in the treatment of GI cancers. J Clin Oncol. 2015 Jun 1;33(16):1737–1744. PubMed PMID: 25918298; eng.
   PubMed Web of Science ®Google Scholar
• Tey J, Soon YY, Koh WY, et al. Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis. Oncotarget. 2017 Apr 11;8(15):25797–25805. PubMed PMID: 28445941; PubMed Central PMCID: PMCPMC5421969. eng.
   PubMedGoogle Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med. 2009;60:167–179. PubMed PMID: 19630570; eng.
   PubMed Web of Science ®Google Scholar
• Zimmerman AL, Wu S. MicroRNAs, cancer and cancer stem cells. Cancer Lett. 2011 Jan 1;300(1):10–19. PubMed PMID: 20965651; PubMed Central PMCID: PMCPMC2991536. eng.
   PubMed Web of Science ®Google Scholar
• Song MY, Pan KF, Su HJ, et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PloS One. 2012;7(3):e33608. PubMed PMID: 22432036; PubMed Central PMCID: PMCPMC3303856. eng.
   PubMed Web of Science ®Google Scholar
• Brenner B, Hoshen MB, Purim O, et al. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011 Sep 21;17(35):3976–3985. PubMed PMID: 22046085; PubMed Central PMCID: PMCPMC3199555. eng.
   PubMed Web of Science ®Google Scholar
• Shen YN, Bae IS, Park GH, et al. MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B. Biomed Pharmacothe. 2018 Sep;105:362–369. PubMed PMID: 29864624; eng.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jin S, Tan S, et al. MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1. Onco Targets Ther. 2019;12:6093–6104. PubMed PMID: 31440062; PubMed Central PMCID: PMCPMC6679680. eng.
   PubMed Web of Science ®Google Scholar
• Wang C, Qiao C. MicroRNA-190b confers radio-sensitivity through negative regulation of Bcl-2 in gastric cancer cells. Biotechnol Lett. 2017 Apr;39(4):485–490. PubMed PMID: 28044223; eng.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402–408. PubMed PMID: 11846609; eng.
   PubMed Web of Science ®Google Scholar
• Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014 Dec;55(12):621–628. PubMed PMID: 25630323; PubMed Central PMCID: PMCPMC4291998. eng.
   PubMed Web of Science ®Google Scholar
• Kim S, Kim JE, Kim N, et al. Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression. Am J Cancer Res. 2019;9(9):2007–2018. PubMed PMID: 31598401; PubMed Central PMCID: PMCPMC6780662. eng.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zheng L, Sun Y, et al. Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells. Oncol Rep. 2015 Jul;34(1):302–310. PubMed PMID: 25998143; eng.
   PubMed Web of Science ®Google Scholar
• Alfonso JCL, Berk L. Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy. Radiat Oncol. 2019 May 30;14(1):88. PubMed PMID: 31146751; PubMed Central PMCID: PMCPMC6543639. eng.
   PubMedGoogle Scholar
• Mirnezami AH, Pickard K, Zhang L, et al. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol. 2009 Apr;35(4):339–347. PubMed PMID: 18644693; eng.
   PubMed Web of Science ®Google Scholar
• Finoux AL, Chartrand P. [Oncogenic and tumour suppressor microRNAs]. Med Sci. 2008 Dec;24(12):1049–1054. PubMed PMID: 19116113; fre.
   Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215–233. PubMed PMID: 19167326; PubMed Central PMCID: PMCPMC3794896. eng.
   PubMed Web of Science ®Google Scholar
• Osaki M, Takeshita F, Ochiya T. MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers. 2008 Nov;13(7):658–670. PubMed PMID: 19096960; eng.
   PubMed Web of Science ®Google Scholar
• Hu S, Zheng Q, Wu H, et al. miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sci. 2017 May 15;177:15–19. PubMed PMID: 28356225; eng.
   PubMed Web of Science ®Google Scholar
• He X, Shu Y. miR-452 promotes the development of gastric cancer via targeting EPB41L3. Pathol Res Pract. 2020 Jan;216(1):152725. PubMed PMID: 31734055; eng.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yu J. MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol. 2018 Feb;96(1):19–25. PubMed PMID: 28482162; eng.
   PubMedGoogle Scholar
• Gao ZY, Liu H, Zhang Z. miR-144-3p increases radiosensibility of gastric cancer cells by targeting inhibition of ZEB1. Clin Transl Oncol. 2021 Mar;23(3):491–500. PubMed PMID: 32613412; eng.
   PubMed Web of Science ®Google Scholar
• Cui FB, Liu Q, Li RT, et al. Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells. Int J Nanomedicine. 2014;9:2345–2358. PubMed PMID: 24872697; PubMed Central PMCID: PMCPMC4026568. eng.
   PubMed Web of Science ®Google Scholar
• Bargiela-Iparraguirre J, Prado-Marchal L, Fernandez-Fuente M, et al. CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response. Sci Rep. 2016 Feb 12;6:21519. PubMed PMID: 26867682; PubMed Central PMCID: PMCPMC4751465. eng.
   PubMed Web of Science ®Google Scholar
• Cassandri M, Smirnov A, Novelli F, et al. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3:17071. PubMed PMID: 29152378; PubMed Central PMCID: PMCPMC5683310. eng.
   PubMed Web of Science ®Google Scholar
• Pan HX, Bai HS, Guo Y, et al. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer. Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):162–170. PubMed PMID: 30767193; eng.
   PubMed Web of Science ®Google Scholar
• Chen G, Chen J, Qiao Y, et al. ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair. Nucleic Acids Res. 2018 Feb 16;46(3):1266–1279. PubMed PMID: 29244158; PubMed Central PMCID: PMCPMC5814808. eng.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou Y, Cheng C, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Apr 2;96(4):597–611. PubMed PMID: 25839328; PubMed Central PMCID: PMCPMC4385186. eng.
   PubMed Web of Science ®Google Scholar
• Smirnov A, Lena AM, Cappello A, et al. ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development. Oncogene. 2019 Mar;38(10):1625–1638. PubMed PMID: 30337687; PubMed Central PMCID: PMCPMC6755960. eng.
   PubMed Web of Science ®Google Scholar
• Lin DC, Hao JJ, Nagata Y, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014 May;46(5):467–473. PubMed PMID: 24686850; PubMed Central PMCID: PMCPMC4070589. eng.
   PubMed Web of Science ®Google Scholar